Universitaetsklinikum Erlangen AöR is the lead sponsor of 2 current clinical trials in our EU (CTIS) register.
Authorised or ongoing trials in the EU Clinical Trials Information System with Universitaetsklinikum Erlangen AöR as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
A Long-Term Follow-Up Study to Assess the Safety and Efficacy of B-Cell-Directed Therapy in Patients with Systemic Autoimmune Disease (B-CARE)
2026-526888-37-00 · Immune System Diseases
|
Phase 1 | Authorised | Germany |
|
A multiCenter phase I study of aUtologous CD19 CAR T cElls for therapy refractory chronic GvHD (CURE-cGvHD)
2025-524468-40-00 · CTIS ↗ · Immune System Diseases
|
Phase 1 | Ongoing | Germany |
| Register | Trials | Recruiting |
|---|---|---|
| EU register (CTIS) | 2 | — |
A trial with sites in more than one country appears in each of those registers.
Universitaetsklinikum Erlangen AöR is the lead sponsor of 2 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 1 October 2026. Completed and withdrawn studies are not counted.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 1 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.